Jesús et al. (2016) indicated that deleterious GBA variants (including L444P mutation) were associated with a more rapid progression to dementia and visual hallucination. On the contrary, benign GBA variants (including E326K mutation) tended to develop dyskinesia (Jesús et al., 2016). The gene discussed is GBA1; the disease is drug-induced dyskinesia.